Association of human cytomegalovirus (HCMV) neutralizing antibodies with antibodies to the HCMV glycoprotein complexes
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1743-422X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Association of human cytomegalovirus (HCMV) neutralizing antibodies with antibodies to the HCMV glycoprotein complexes ; volume:17 ; number:1 ; day:3 ; month:8 ; year:2020 ; pages:1-10 ; date:12.2020
Virology journal ; 17, Heft 1 (3.8.2020), 1-10, 12.2020
- Urheber
-
Shibamura, Miho
Yoshikawa, Tomoki
Yamada, Souichi
Inagaki, Takuya
Nguyen, Phu Hoang Anh
Fujii, Hikaru
Harada, Shizuko
Fukushi, Shuetsu
Oka, Akira
Mizuguchi, Masashi
Saijo, Masayuki
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12985-020-01390-2
- URN
-
urn:nbn:de:101:1-2020092822342934397435
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shibamura, Miho
- Yoshikawa, Tomoki
- Yamada, Souichi
- Inagaki, Takuya
- Nguyen, Phu Hoang Anh
- Fujii, Hikaru
- Harada, Shizuko
- Fukushi, Shuetsu
- Oka, Akira
- Mizuguchi, Masashi
- Saijo, Masayuki
- SpringerLink (Online service)
Ähnliche Objekte (12)
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies
Neutralizing Antibodies to Antigenic Domain 5 of Glycoprotein B of Human Cytomegalovirus
Human Cytomegalovirus (HCMV)-based Therapeutic Cancer Vaccines
Suppressive effects of pterostilbene on human cytomegalovirus (HCMV) infection and HCMV-induced cellular senescence
Etablierung eines in-vitro-Persistenzmodells für das menschliche Cytomegalovirus (HCMV) mit Hilfe selektionierbarer Mutanten von HCMV
Protection from cytomegalovirus infection by glycoprotein-specific monoclonal antibodies
Protection from Cytomegalovirus Infection by Glycoprotein-specific Monoclonal Antibodies
Funktionelle Analyse des Tegumentproteins pp65 des menschlichen Cytomegalovirus (HCMV)
Human Cytomegalovirus (HCMV) induces Human Endogenous Retrovirus (HERV) transcription
Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies
Verwendung rekombinanter Antigene zur serologischen Diagnose des humanen Cytomegalovirus (HCMV)
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies
Neutralizing Antibodies to Antigenic Domain 5 of Glycoprotein B of Human Cytomegalovirus
Human Cytomegalovirus (HCMV)-based Therapeutic Cancer Vaccines
Suppressive effects of pterostilbene on human cytomegalovirus (HCMV) infection and HCMV-induced cellular senescence
Etablierung eines in-vitro-Persistenzmodells für das menschliche Cytomegalovirus (HCMV) mit Hilfe selektionierbarer Mutanten von HCMV
Protection from cytomegalovirus infection by glycoprotein-specific monoclonal antibodies
Protection from Cytomegalovirus Infection by Glycoprotein-specific Monoclonal Antibodies
Funktionelle Analyse des Tegumentproteins pp65 des menschlichen Cytomegalovirus (HCMV)
Human Cytomegalovirus (HCMV) induces Human Endogenous Retrovirus (HERV) transcription
Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies
Verwendung rekombinanter Antigene zur serologischen Diagnose des humanen Cytomegalovirus (HCMV)
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies
Neutralizing Antibodies to Antigenic Domain 5 of Glycoprotein B of Human Cytomegalovirus
Human Cytomegalovirus (HCMV)-based Therapeutic Cancer Vaccines
Suppressive effects of pterostilbene on human cytomegalovirus (HCMV) infection and HCMV-induced cellular senescence
Etablierung eines in-vitro-Persistenzmodells für das menschliche Cytomegalovirus (HCMV) mit Hilfe selektionierbarer Mutanten von HCMV
Protection from cytomegalovirus infection by glycoprotein-specific monoclonal antibodies
Protection from Cytomegalovirus Infection by Glycoprotein-specific Monoclonal Antibodies
Funktionelle Analyse des Tegumentproteins pp65 des menschlichen Cytomegalovirus (HCMV)
Human Cytomegalovirus (HCMV) induces Human Endogenous Retrovirus (HERV) transcription
Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies